Marea Therapeutics Announces Late-Breaking Oral Presentation at the 93rd EAS Congress

Carbonatix Pre-Player Loader

Audio By Carbonatix

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Apr 15, 2025--

Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases, today announced two upcoming presentations at the 93rd European Atherosclerosis Society (EAS) Congress being held May 4-7, 2025 in Glasgow, UK.

Details of the oral presentations are as follows:

Title: A Novel ANGPTL4 Inhibitory Antibody Safely Lowers Plasma Triglycerides and Remnant Cholesterol in Humans
Abstract Number: 1320
Session Title: Late Breaker Session: Clinical
Session Date and Time: Wednesday, May 7, 2025, 11:00 a.m. – 12:30 p.m. BST


Title: Real-world Analysis of the Association of Remnant Cholesterol Levels with Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease
Abstract Number: 1314
Session Title: SaaG Session: Epidemiology: From Prevention to Prognosis
Session Date and Time: Tuesday, May 6, 2025, 2:35 p.m. – 3:35 p.m. BST

About Marea Therapeutics

Marea Therapeutics is a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases. The company’s lead program, MAR001, is in Phase 2 clinical development for adults with metabolic dysfunction and high risk for cardiovascular disease. The company is also advancing MAR002 for the treatment of acromegaly. To learn more, please visit www.mareatx.com and follow us on LinkedIn and X.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250414755079/en/

CONTACT: Media Contact:

Katie Engleman, 1AB

[email protected]

KEYWORD: EUROPE UNITED STATES UNITED KINGDOM NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: RESEARCH GENETICS CLINICAL TRIALS CARDIOLOGY BIOTECHNOLOGY OTHER HEALTH HEALTH PHARMACEUTICAL SCIENCE

SOURCE: Marea Therapeutics, Inc.

Copyright Business Wire 2025.

PUB: 04/15/2025 08:00 AM/DISC: 04/15/2025 08:00 AM

http://www.businesswire.com/news/home/20250414755079/en

 

Salem News Channel Today

Sponsored Links

On Air & Up Next

  • The Larry Elder Show
    7:00PM - 10:00PM
     
    Larry Elder personifies the phrase “We’ve Got a Country to Save” The “Sage from   >>
     
  • The Mark Levin Show
    10:00PM - 12:00AM
     
    Mark Levin is one of America's preeminent conservative commentators and   >>
     
  • The Mark Levin Show
    12:00AM - 1:00AM
     
    Mark Levin is one of America's preeminent conservative commentators and   >>
     
  • The Mike Gallagher Show
    1:00AM - 3:00AM
     
    We’re excited to welcome Katie Pavlich, Fox News contributor and Townhall   >>
     
  • Eric Metaxas Show
    3:00AM - 5:00AM
     
    The Eric Metaxas Show offers compelling perspective on American culture,   >>
     

See the Full Program Guide